✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹11,124 Cr.
P/E
55.62
  • Sanofi Cons. Health
  • Sanofi India
  • Rubicon Research

FAQs on Sanofi Consumer Healthcare India Ltd. Shareprice

Sanofi Cons. Health has given lower returns compared to its competitors.
Sanofi Cons. Health has grown at ~-3.42% over the last 1yrs while peers have grown at a median rate of 2.0%

Sanofi Cons. Health is not expensive.
Latest PE of Sanofi Cons. Health is 55.13, while 3 year average PE is 63.27.
Also latest EV/EBITDA of Sanofi Cons. Health is 41.67 while 3yr average is 45.06.

Growth Table

  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Balance Sheet

  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Cash Flow

  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Quarterly Results

  • Sanofi Consumer Healthcare India Ltd.
  • Sanofi India
  • Rubicon Research

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Sanofi Consumer Healthcare India Ltd. Financials

Balance sheet of Sanofi Cons. Health is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Sanofi Cons. Health is increasing.
Latest net debt of Sanofi Cons. Health is -₹216.9 Crs as of Jun-25.
This is greater than Dec-24 when it was -₹653.8 Crs.

Yes, profit is increasing.
The profit of Sanofi Cons. Health is ₹200 Crs for TTM, ₹181 Crs for Dec 2024 and ₹165 Crs for Dec 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sanofi Cons. Health latest dividend payout ratio is 69.89% and 3yr average dividend payout ratio is 37.98%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech